A detailed history of Pallas Capital Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 22,946 shares of AMGN stock, worth $7.13 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
22,946
Previous 21,693 5.78%
Holding current value
$7.13 Million
Previous $6.25 Million 4.42%
% of portfolio
0.28%
Previous 0.35%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$268.87 - $324.56 $336,894 - $406,673
1,253 Added 5.78%
22,946 $6.52 Million
Q4 2023

Jan 22, 2024

BUY
$255.7 - $288.46 $73,130 - $82,499
286 Added 1.34%
21,693 $6.25 Million
Q3 2023

Nov 01, 2023

BUY
$218.65 - $271.46 $487,152 - $604,812
2,228 Added 11.62%
21,407 $5.75 Million
Q2 2023

Jul 26, 2023

SELL
$214.27 - $253.37 $17,784 - $21,029
-83 Reduced 0.43%
19,179 $4.26 Million
Q1 2023

May 02, 2023

BUY
$225.79 - $275.2 $358,102 - $436,467
1,586 Added 8.97%
19,262 $4.66 Million
Q4 2022

Jan 24, 2023

SELL
$229.03 - $291.01 $5,038 - $6,402
-22 Reduced 0.12%
17,676 $0
Q3 2022

Nov 07, 2022

BUY
$224.46 - $253.15 $205,829 - $232,138
917 Added 5.46%
17,698 $4.71 Million
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $216,405 - $240,822
-938 Reduced 5.29%
16,781 $4.13 Million
Q1 2022

Apr 20, 2022

BUY
$219.27 - $242.57 $405,210 - $448,269
1,848 Added 11.64%
17,719 $4.5 Million
Q4 2021

Feb 01, 2022

BUY
$198.88 - $227.6 $197,090 - $225,551
991 Added 6.66%
15,871 $3.61 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $1.09 Million - $1.28 Million
5,132 Added 52.65%
14,880 $3.25 Million
Q2 2021

Aug 11, 2021

BUY
$233.58 - $259.14 $380,268 - $421,879
1,628 Added 20.05%
9,748 $2.23 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $1.8 Million - $2.1 Million
8,120 New
8,120 $2.05 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pallas Capital Advisors LLC Portfolio

Follow Pallas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.